UNITED STATES
SECURITIESAND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.)
| ☒ | Filed by the Registrant |
|
|
|
| ☐ | Filed by a Party other than the Registrant |
|
|
|
| Check the appropriate box: | |
|
|
|
| ☐ | Preliminary Proxy Statement |
|
|
|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
| ☐ | Definitive Proxy Statement |
|
|
|
| ☒ | Definitive Additional Materials |
|
|
|
| ☐ | Soliciting Material Under §240.14a-12 |
| Zivo Bioscience, Inc. |
| (Name of Registrant as Specified In Its Charter) |
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required. |
|
|
|
| ☐ | Fee paid previously with preliminary materials. |
|
|
|
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| 2 |
| 3 |